NCT04710693 is a NA clinical trial of CAD polyp-detection system in Colonic Polyp, sponsored by London North West Healthcare NHS Trust.

Who is sponsoring NCT04710693?

NCT04710693 is sponsored by London North West Healthcare NHS Trust.

What drugs are being tested in NCT04710693?

Interventions in NCT04710693: CAD polyp-detection system.

What condition does NCT04710693 study?

NCT04710693 studies Colonic Polyp.

Is NCT04710693 still recruiting?

NCT04710693 is currently completed. Last updated 22 December 2021.

Last reviewed 2021-12-22 · How we verify

NCT04710693

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Implementation of Optical Diagnosis of Diminutive Colorectal Polyps: DISCARD3 Study (Incorporating AI-DETECT)

Completed NA Last updated 22 December 2021

What this trial tests

NA trial testing CAD polyp-detection system in Colonic Polyp in 614 participants. Completed in 3 December 2021.

Timeline

14 February 2020

Primary endpoint
3 December 2021

3 December 2021

Quick facts

Lead sponsor	London North West Healthcare NHS Trust
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	diagnostic
Enrollment	614
Start date	14 February 2020
Primary completion	3 December 2021
Estimated completion	3 December 2021
Sites	1 location across United Kingdom

Drugs / interventions tested

CAD polyp-detection system

Conditions studied

Colonic Polyp — all drugs for Colonic Polyp →

Sponsor

London North West Healthcare NHS Trust — full company profile →

Who can join

Adults 55 to 74, any sex, with Colonic Polyp. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This is a prospective feasibility study. The aim of this work is to assess the acceptability and feasibility of optical diagnosis-led care in bowel cancer screening patients undergoing colonoscopy. This study will determine whether bowel cancer screening colonoscopists are able to consistently record and diagnose diminutive adenomas suitable for a resect and discard strategy allowing assignment of surveillance intervals according to Preservation and Incorporation of Valuable Endoscopic Innovations (PIVI) criteria. A practical quality assurance program around optical diagnosis will be introduced. The use of a CAD polyp-detection system will also be evaluated (AI-DETECT).

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Implementation of optical diagnosis with a "resect and discard" strategy in clinical practice: DISCARD3 study.
Ahmad A, Moorghen M, Wilson A, Stasinos I, et al · · 2022 · cited 23× · PMID 35724693 · DOI 10.1016/j.gie.2022.06.019

Verify or expand the search:

Other recruiting trials for Colonic Polyp

Currently open trials in the same condition.

NCT06550908 — Training Physicians to Differentiate the Paris Classification Using Artificial Colon Polyp Images · NA · recruiting
NCT07456111 — A Comparison of Remimazolam Besylate and Propofol Sedation in Patients Undergoing Colonoscopic Polypectomy · Phase 4 · recruiting
NCT06483503 — Extra Wide Field of View Lens Study · active not recruiting
NCT06077435 — Comparative Analysis of AI Software for Enhanced Polyp Detection and Diagnosis · NA · recruiting

Other London North West Healthcare NHS Trust trials

Trials by the same sponsor.

NCT07271264 — A Randomised Paired Design Study of Texture and Colour Enhancement Imaging (TXI) Versus High-definition White Light Endo · NA · recruiting
NCT07298655 — 3D Contrast Enhanced Microvascular Ultrasound of Carotid Atherosclerosis for the Detection of Carotid Plaque Neo-Revascu · NA · recruiting
NCT07208214 — Texture and Colour Enhancement Imaging (TXI) Versus Dye Chromoendoscopy for Dysplasia Detection in IBD Surveillance. · NA · not yet recruiting
NCT05583968 — Efficiency of AI Reporting (EAIR). · withdrawn
NCT06447961 — PSYLIVED: the Psychological Impacts of Living With an Inherited Colorectal Cancer Predisposition Syndrome · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04710693 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by London North West Healthcare NHS Trust
Last refreshed: 22 December 2021

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04710693.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing